Literature DB >> 3382815

Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers.

E Vining, T R Kosten, H D Kleber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3382815     DOI： 10.1111/j.1360-0443.1988.tb02576.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN： 0952-0481


× No keyword cloud information.
  15 in total

Review 1.  Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.

Authors:  Stacey C Sigmon; Adam Bisaga; Edward V Nunes; Patrick G O'Connor; Thomas Kosten; George Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2012-03-12       Impact factor: 3.829

2.  Ambulatory opiate detoxification and primary care: a role for the primary care physician.

Authors:  P G O'Connor; M E Waugh; R S Schottenfeld; I A Diakogiannis; B J Rounsaville
Journal:  J Gen Intern Med       Date:  1992 Sep-Oct       Impact factor: 5.128

Review 3.  Pharmacological strategies for detoxification.

Authors:  Alison M Diaper; Fergus D Law; Jan K Melichar
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

4.  Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.

Authors:  Maria Korak-Leiter; Rudolf Likar; Michael Oher; Ernst Trampitsch; Gerda Ziervogel; Joseph V Levy; Enno C Freye
Journal:  Intensive Care Med       Date:  2005-02-16       Impact factor: 17.440

5.  Non completers of opiate detoxification program.

Authors:  A K Nigam; R Ray; B M Tripathi
Journal:  Indian J Psychiatry       Date:  1992-10       Impact factor: 1.759

6.  Primary care-based ambulatory opioid detoxification: the results of a clinical trial.

Authors:  P G O'Connor; M E Waugh; K M Carroll; B J Rounsaville; I A Diagkogiannis; R S Schottenfeld
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

Review 7.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

Review 8.  Treatment of heroin (diamorphine) addiction: current approaches and future prospects.

Authors:  Gerardo Gonzalez; Alison Oliveto; Thomas R Kosten
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence.

Authors:  Angela J Dean; John B Saunders; Rod T Jones; Ross M Young; Jason P Connor; Bruce R Lawford
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

10.  Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents.

Authors:  Hassan Ziaaddini; Mansooreh Nasirian; Nouzar Nakhaee
Journal:  Addict Health       Date:  2012 Summer-Autumn
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.